Back to top
more

Franklin Strategic Biotechnology Discovery Fund Class A: (MF: FBDIX)

(NASDAQ Mutual Funds) As of Jan 27, 2023 08:00 PM ET

$113.03 USD

+0.11 (0.10%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

4-Sell of 5       4  

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Dec 31, 2022

Total Return %* Percentile Rank Objective
YTD -12.65 71
3 months 7.22 84
6 months 9.19 21
1 Year -12.66 71
3 Year -2.26 94
5 Year 1.19 98
10 Year 9.54 94

* Annual for three years and beyond.

Zacks Premium Research for FBDIX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Sell 4
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 24.48
% Yield 0.12
% SEC Yield NA
Net Assets (Mil $) 12/31/2022 685.67
%Turnover 12/31/2022 26.25

Risk

3 Year 5 Year 10 Year
Beta 0.58 0.76 0.89
Alpha -5.97 -4.81 0.26
R Squared 0.36 0.42 0.32
Std. Dev. 20.24 22.13 23.53
Sharpe -0.05 0.11 3.00

Sector / Country Weightings

As of 12/31/2022 % of Portfolio
Health 75.96
Other 9.79
Technology 5.60
Services 5.20
Industrial Cyclical 3.45

Portfolio Holdings

Top Equity Holdings
(As of 7/31/2022)
% of Portfolio Value (Mil$)
VERTEX PHARMACEUTICALS IN 7.87 65.63
AMGEN INC 7.70 64.18
HORIZON THERAPEUTICS PUBL 5.24 43.71
JAZZ PHARMACEUTICALS PLC 5.12 42.69
REGENERON PHARMACEUTICALS 4.87 40.62
GILEAD SCIENCES INC 4.41 36.74
ASTRAZENECA PLC ADR 3.99 33.25
SEAGEN INC 3.90 32.52
PTC THERAPEUTICS INC 3.49 29.08

Stock Holding % of Net Assets

As Of 7/31/2022
Total Issues 68
Avg. P/E 38.96
Avg. P/Book 4.93
Avg. EPS Growth 9.99
Avg. Market Value (Mil $) 46,478

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 69.70
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00